Upper Tract Urothelial Carcinoma Clinical Trials

25 clinical trials for Upper Tract Urothelial Carcinoma across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Validation of a Circulating Tumor DNA Blood Test in Muscle-Invasive Bladder and Upper Tract Urothelial Cancer — RECRUITING
• Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA — RECRUITING · PHASE2
• Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis — RECRUITING
• Radical Nephroureterectomy With vs Without Template Lymph Node Dissection in High-Risk Upper Tract Urothelial Carcinoma (T-LND UTUC) — RECRUITING · NA
• Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma — RECRUITING · PHASE1
• A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial — RECRUITING · NA
• Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC — RECRUITING · PHASE2
• Ambulatory Flexible URS for UTUC Surveillance — RECRUITING · PHASE1
• Neoadjuvant Tislelizumab in Combination With Nab-Paclitaxel for UTUC — RECRUITING · PHASE2
• A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma — RECRUITING · PHASE2
• OptiCross HD IVUS for Assessing Invasion Depth in Upper Tract Urothelial Carcinoma — NOT_YET_RECRUITING · NA
• Biomarker-Enriched Kidney-Preserving Strategy With Disitamab Vedotin Plus Tislelizumab in HER2-Positive High-Risk Upper Tract Urothelial Carcinoma — NOT_YET_RECRUITING · PHASE2
• Flexible Ureterorenoscopy for Surveillance of Upper Tract Urothelial Carcinoma — NOT_YET_RECRUITING · NA
• Multimodal Kidney-Sparing Strategy for High-Risk Upper Tract Urothelial Carcinoma — NOT_YET_RECRUITING
• Disitamab Vedotin Plus Radiotherapy for Adjuvant Treatment of HER2-Expressing Cisplatin-Ineligible Upper Tract Urothelial Carcinoma — NOT_YET_RECRUITING · PHASE2
• NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUC — NOT_YET_RECRUITING · PHASE2
• Treatment of Tumors in the Urinary Collecting System of the Kidney or Ureter Using a Light Activated Drug (WST11) — COMPLETED · PHASE1
• HEFTME System for Adjuvant Therapeutic Selection of Locally Advanced UTUC Postoperatively：A Perspective Cohort Study — NOT_YET_RECRUITING
• Feasibility of Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma — OTHER · PHASE2
• Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for Upper Tract Urothelial Carcinoma Detection — OTHER
• Feasibility and Safety of Extraperitoneal Laparoscopic Extended Retroperitoneal Lymph Node Dissection at Time of Nephroureterectomy for Upper Tract Urothelial Carcinoma — OTHER
• Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Diagnostic Ureteroscopy for Primary Upper Tract Urothelial Carcinoma Patients — OTHER · PHASE2
• Lymph Node Dissection in High-risk UTUC(Upper Tract Urothelial Carcinoma) — OTHER · NA
• Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients — OTHER · PHASE2
• Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas — OTHER · PHASE2

Refine this search